Question
To ask Her Majesty’s Government, further to the Written Answers by Lord Darzi of Denham on 23 October 2007 (WA101), by Lord Triesman on 12 November 2007 (WA1–2), by Baroness Neville-Rolfe on 8 June 2015 (HL44) and by Lord Prior of Brampton on 11 February (HL5648), how the Human Fertilisation and Embryology Authority (HFEA) has rigorously checked that what is stated in centres’ lay summaries on its website about the purposes and likelihood of success of the research is realistic for both donors and the public, as explicitly recommended under "Key actions for HFEA" in the summary of the "Post Hwang Meeting" on 1 March 2006 that was published on the HFEA website; and how the currently stated aim of research licence R0152 "to improve outcomes of ART for the treatment of infertility" relates to any reasonably foreseeable applications of nuclear transfer that accord not only with the statutory tests but also with the originally stated purpose of the proposed research in the initial application for this particular licence.
Answer
The Human Fertilisation and Embryology Authority (HFEA) has advised that centres’ lay summaries are checked at inspection by the relevant HFEA inspector and by the HFEA Licence Committee. In the case of licence R0152, the lay summary was last approved on 15 July 2015 when the HFEA Licence Committee agreed to approve updates to the centre’s lay summary and the updates to the research objectives. The minutes note the committee was content that the revised objectives and lay summary were consistent with the activities and purposes for which the project was licensed.